Is antihistaminergic H2 really useful in prevention of hypersensitivity induced by paclitaxel?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s00520-016-3366-0.pdf
Reference20 articles.
1. Gatesman ML, Smith TJ (2011) The shortage of essential chemotherapy drugs in the United States. N Engl J Med 365(8):1653–1655
2. Gogineni K, Shuman KL, Emanuel EJ (2013) Survey of oncologists about shortages of cancer drugs. N Engl J Med 369(25):2463–2464
3. Metzger ML, Billett A, Link MP (2012) The impact of drug shortages on children with cancer—the example of mechlorethamine. N Engl J Med 367(26):2461–2463
4. de Lemos ML, Waignein S, de Haan M (2016) Evidence-based practice in times of drug shortage. J Oncol Pharm Pract 22(3):566–570
5. Shank BR, Seung AH, Kinsman K, Newman MJ, Donehover RC, Burton B (2016) Effect of the leucovorin shortage: pilot study investigating cost, efficacy, and toxicity comparison of low fixed-dose versus body surface area-adjusted leucovorin dosing in patients with resectable colon or metastatic colorectal cancer. J Oncol Pharm Pract. doi: 10.1177/1078155215624262
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study);European Journal of Clinical Pharmacology;2023-07-13
2. Ranitidine and the incidence of hypersensitivity reactions to paclitaxel: A retrospective cohort study;Pharmacology Research & Perspectives;2022-07-10
3. H2 blockers in the prevention of paclitaxel-related hypersensitivity reaction;The National Medical Journal of India;2022-07-06
4. Histamine‐2 (H 2 ) antagonists can be safely removed from standard paclitaxel premedication regimens;British Journal of Clinical Pharmacology;2022-05-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3